Momenta, Sandoz Play Patent Defense For A Change, Seek Injunction To Prevent Teva From Launching Generic Lovenox

Firms claim Teva, which now seems close to approval, cannot manufacture enoxaparin to match Sanofi's branded Lovenox without infringing Momenta's manufacturing process.